Stockreport

NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) Shares Could Be 46% Below Their Intrinsic Value Estimate [Yahoo! Finance]

NewAmsterdam Pharma Company N.V. - Ordinary Shares  (NAMS) 
PDF Current share price of US$24.12 suggests NewAmsterdam Pharma is potentially 46% undervalued Analyst price target for NAMS is US$38.38 which is 14% below our fair valu [Read more]